CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: report from the laboratory science …
GL Myers, N Rifai, RP Tracy, WL Roberts… - Circulation, 2004 - Am Heart Assoc
GL Myers, N Rifai, RP Tracy, WL Roberts, RW Alexander, LM Biasucci, JD Catravas…
Circulation, 2004•Am Heart AssocDiscussion The Laboratory Science Discussion Group was charged with reviewing the
available analytical data on inflammatory markers and recommending those, if any, that
were ready to move from the research setting into the routine clinical laboratory. The
markers were divided into 3 groups of molecules: cytokines and chemokines, soluble
adhesion molecules, and acute-phase reactants. The laboratory group primarily focused on
the availability of commercial assays, their limitations and strengths, ability to standardize …
available analytical data on inflammatory markers and recommending those, if any, that
were ready to move from the research setting into the routine clinical laboratory. The
markers were divided into 3 groups of molecules: cytokines and chemokines, soluble
adhesion molecules, and acute-phase reactants. The laboratory group primarily focused on
the availability of commercial assays, their limitations and strengths, ability to standardize …
Discussion
The Laboratory Science Discussion Group was charged with reviewing the available analytical data on inflammatory markers and recommending those, if any, that were ready to move from the research setting into the routine clinical laboratory. The markers were divided into 3 groups of molecules: cytokines and chemokines, soluble adhesion molecules, and acute-phase reactants. The laboratory group primarily focused on the availability of commercial assays, their limitations and strengths, ability to standardize assay results, assay performance, and how results should be interpreted for assessing the risk of future CVD.
Am Heart Assoc